Cargando…

Active pulmonary interstitial fibrosis in a COVID-19 survivor diagnosed by transbronchial lung cryobiopsy six months after onset

We present a 76-year-old man who visited our center because of persistent dyspnea with hypoxia on exertion 6 months after onset of coronavirus disease 2019. Chest computed tomography showed bilateral extensive subpleural reticulation with traction bronchiectasis predominantly in the lower lung lobes...

Descripción completa

Detalles Bibliográficos
Autores principales: Muto, Yutaka, Okudela, Koji, Nakazawa, Atsuhito, Hisakane, Kakeru, Matsumura, Mai, Takemura, Tamiko, Iwasawa, Tae, Ogura, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234020/
http://dx.doi.org/10.1016/j.hpr.2022.300666
_version_ 1784735959321935872
author Muto, Yutaka
Okudela, Koji
Nakazawa, Atsuhito
Hisakane, Kakeru
Matsumura, Mai
Takemura, Tamiko
Iwasawa, Tae
Ogura, Takashi
author_facet Muto, Yutaka
Okudela, Koji
Nakazawa, Atsuhito
Hisakane, Kakeru
Matsumura, Mai
Takemura, Tamiko
Iwasawa, Tae
Ogura, Takashi
author_sort Muto, Yutaka
collection PubMed
description We present a 76-year-old man who visited our center because of persistent dyspnea with hypoxia on exertion 6 months after onset of coronavirus disease 2019. Chest computed tomography showed bilateral extensive subpleural reticulation with traction bronchiectasis predominantly in the lower lung lobes. Transbronchial lung cryobiopsy revealed spatially and temporally intermittent interstitial fibrosis with mild lymphoid cell infiltration. Not only were there membranous fibrotic scars on the alveolar septa, but there were scattered foci of alveolar collapse with young fibroblastic proliferations, suggesting progressive interstitial fibrotic lesions. In addition to fibrotic phase of diffuse alveolar damage, the acceleration of subclinical preexisting interstitial lung abnormalities might have affected his respiratory condition.
format Online
Article
Text
id pubmed-9234020
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Authors. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-92340202022-06-27 Active pulmonary interstitial fibrosis in a COVID-19 survivor diagnosed by transbronchial lung cryobiopsy six months after onset Muto, Yutaka Okudela, Koji Nakazawa, Atsuhito Hisakane, Kakeru Matsumura, Mai Takemura, Tamiko Iwasawa, Tae Ogura, Takashi Human Pathology Reports Article We present a 76-year-old man who visited our center because of persistent dyspnea with hypoxia on exertion 6 months after onset of coronavirus disease 2019. Chest computed tomography showed bilateral extensive subpleural reticulation with traction bronchiectasis predominantly in the lower lung lobes. Transbronchial lung cryobiopsy revealed spatially and temporally intermittent interstitial fibrosis with mild lymphoid cell infiltration. Not only were there membranous fibrotic scars on the alveolar septa, but there were scattered foci of alveolar collapse with young fibroblastic proliferations, suggesting progressive interstitial fibrotic lesions. In addition to fibrotic phase of diffuse alveolar damage, the acceleration of subclinical preexisting interstitial lung abnormalities might have affected his respiratory condition. The Authors. Published by Elsevier Inc. 2022-09 2022-06-27 /pmc/articles/PMC9234020/ http://dx.doi.org/10.1016/j.hpr.2022.300666 Text en © 2022 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Muto, Yutaka
Okudela, Koji
Nakazawa, Atsuhito
Hisakane, Kakeru
Matsumura, Mai
Takemura, Tamiko
Iwasawa, Tae
Ogura, Takashi
Active pulmonary interstitial fibrosis in a COVID-19 survivor diagnosed by transbronchial lung cryobiopsy six months after onset
title Active pulmonary interstitial fibrosis in a COVID-19 survivor diagnosed by transbronchial lung cryobiopsy six months after onset
title_full Active pulmonary interstitial fibrosis in a COVID-19 survivor diagnosed by transbronchial lung cryobiopsy six months after onset
title_fullStr Active pulmonary interstitial fibrosis in a COVID-19 survivor diagnosed by transbronchial lung cryobiopsy six months after onset
title_full_unstemmed Active pulmonary interstitial fibrosis in a COVID-19 survivor diagnosed by transbronchial lung cryobiopsy six months after onset
title_short Active pulmonary interstitial fibrosis in a COVID-19 survivor diagnosed by transbronchial lung cryobiopsy six months after onset
title_sort active pulmonary interstitial fibrosis in a covid-19 survivor diagnosed by transbronchial lung cryobiopsy six months after onset
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234020/
http://dx.doi.org/10.1016/j.hpr.2022.300666
work_keys_str_mv AT mutoyutaka activepulmonaryinterstitialfibrosisinacovid19survivordiagnosedbytransbronchiallungcryobiopsysixmonthsafteronset
AT okudelakoji activepulmonaryinterstitialfibrosisinacovid19survivordiagnosedbytransbronchiallungcryobiopsysixmonthsafteronset
AT nakazawaatsuhito activepulmonaryinterstitialfibrosisinacovid19survivordiagnosedbytransbronchiallungcryobiopsysixmonthsafteronset
AT hisakanekakeru activepulmonaryinterstitialfibrosisinacovid19survivordiagnosedbytransbronchiallungcryobiopsysixmonthsafteronset
AT matsumuramai activepulmonaryinterstitialfibrosisinacovid19survivordiagnosedbytransbronchiallungcryobiopsysixmonthsafteronset
AT takemuratamiko activepulmonaryinterstitialfibrosisinacovid19survivordiagnosedbytransbronchiallungcryobiopsysixmonthsafteronset
AT iwasawatae activepulmonaryinterstitialfibrosisinacovid19survivordiagnosedbytransbronchiallungcryobiopsysixmonthsafteronset
AT oguratakashi activepulmonaryinterstitialfibrosisinacovid19survivordiagnosedbytransbronchiallungcryobiopsysixmonthsafteronset